Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: May 6, 2024
Date Accepted: Dec 18, 2024

The final, peer-reviewed published version of this preprint can be found here:

Effects of Individualized Follow-Up With an App Postcardiac Rehabilitation: Five-Year Follow-Up of a Randomized Controlled Trial

Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB

Effects of Individualized Follow-Up With an App Postcardiac Rehabilitation: Five-Year Follow-Up of a Randomized Controlled Trial

J Med Internet Res 2025;27:e60256

DOI: 10.2196/60256

PMID: 39946716

PMCID: 11888047

Effects of individualized follow-up with an app post-cardiac rehabilitation: Five-years follow-up of a randomized controlled trial

  • Pernille Lunde; 
  • Asta Bye; 
  • Jostein Grimsmo; 
  • Are Hugo Pripp; 
  • Vibeke Ritschel; 
  • Even Jarstad; 
  • Birgitta Blakstad Nilsson

ABSTRACT

Background:

Adherence to healthy behaviours, initiated and/or adapted in cardiac rehabilitation (CR) is challenging and few patients meet the guideline standards for secondary prevention. In a former study, we demonstrated increased adherence to healthy behaviour one-year post-CR when using an app for individualized follow-up. It is still uncertain whether these effects persist when the follow-up cease. The aim of this study was to examine the long-term effects, four years post-intervention of the individualized follow-up with an app.

Objective:

The aim of this study was to examine the long-term effects, four years post-intervention of the individualized follow-up with an app.

Methods:

A single-blinded multicentre randomized controlled trial was designed. The intervention group (IG) received individualized follow-up with an app for one year, while the control group (CG) received usual care. Primary outcome was difference in peak oxygen uptake (VO2peak). Secondary outcomes included exercise performance, bodyweight, blood pressure, lipid profile, exercise habits, health related quality of life, health status, cardiac events, and physical activity. Linear mixed models for repeated measurements were used to analyse for differences between groups. All tests were two-sided, and p-values ≤0.05 were considered as statistically significant.

Results:

At five-year follow-up, 101 out of the initial 113 randomized were reassessed. Intention-to-treat analyses using a mixed model for repeated measurements, showed a statistically significant difference in exercise habits in favour of the IG. Statistically significant differences were also found in triglycerides and walking, but in favour of the CG. No statistically significant differences were observed between the groups for other evaluated outcomes.

Conclusions:

Most of the benefits derived from the app-based follow-up ceased by the five-years follow-up. Although the IG reported statistically significant higher levels of exercise, this was not translated into better VO2peak or exercise performance. Our study underlines the need of follow-up from healthcare providers to increase the chance to succeed with adherence to healthy behaviour post-CR. Clinical Trial: ClinicalTrials.gov: NCT05697120


 Citation

Please cite as:

Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB

Effects of Individualized Follow-Up With an App Postcardiac Rehabilitation: Five-Year Follow-Up of a Randomized Controlled Trial

J Med Internet Res 2025;27:e60256

DOI: 10.2196/60256

PMID: 39946716

PMCID: 11888047

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.